 |
인쇄하기
취소
|
Cultured Epidermal Homograft Developed by Domestic Company
The Korea Food and Drug Administration (KFDA) said it has approved market authorization of Tego Science's Kaloderm, a cultured epidermal homograft (CEH) for skin replacement and wound healing, effective March 21st.
According to the company, Kaloderm carries out the protective functions of the conventional dressing and simultaneously releases various growth factors that promote reepitheliali...
According to the company, Kaloderm carries out the protective functions of the conventional dressing and simultaneously releases various growth factors that promote reepitheliali...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.